Abstract
Background: The number of people taking prescribed medication for anxiety and depression has increased greatly, but little is known of how this medication impacts on safety at work.
Aims: To examine the relation between anxiety and depression, prescribed medication, performance, and safety in the workplace.
Methods: The research involved nine focus groups with sufferers of anxiety and depression to investigate experiences of mental health problems and the impact of psychotropic drugs. A further three focus groups were conducted with staff in human resources, personnel, occupational health, and health and safety departments, to explore organisational perspectives. The sample comprised 74 individuals drawn from a wide range of occupational sectors. Finally, the results were presented to a panel of experts from occupational medicine, general practice, psychology, health and safety, and psychiatry, to consider the implications for practice.
Results: Workers reported that both the symptoms and the medication impaired work performance. Participants described accidents which they attributed to their condition or to the medication. Workers with responsibilities for others, such as teachers, healthcare workers, and managers appeared to present a particular safety risk. Healthcare workers believed that they placed themselves and their patients at risk when carrying out medical procedures.
Conclusions: Respondents in this study felt that their symptoms of anxiety and depression and the medication they took to treat these conditions placed them at risk with respect to safety in the workplace. Drawing on the results, the authors outline areas for improvement in the management of mental health problems at work.
Full Text
The Full Text of this article is available as a PDF (83.7 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Cohen A. F., Posner J., Ashby L., Smith R., Peck A. W. A comparison of methods for assessing the sedative effects of diphenhydramine on skills related to car driving. Eur J Clin Pharmacol. 1984;27(4):477–482. doi: 10.1007/BF00549598. [DOI] [PubMed] [Google Scholar]
- Cropley M., Steptoe A., Joekes K. Job strain and psychiatric morbidity. Psychol Med. 1999 Nov;29(6):1411–1416. doi: 10.1017/s003329179900121x. [DOI] [PubMed] [Google Scholar]
- DeHart R. L. Medication and the work environment. J Occup Med. 1990 Apr;32(4):310–312. doi: 10.1097/00043764-199004000-00010. [DOI] [PubMed] [Google Scholar]
- Edwards J. G. Depression, antidepressants, and accidents. BMJ. 1995 Oct 7;311(7010):887–888. doi: 10.1136/bmj.311.7010.887. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lader M. Treatment of anxiety. BMJ. 1994 Jul 30;309(6950):321–324. doi: 10.1136/bmj.309.6950.321. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lawrenson R. A., Tyrer F., Newson R. B., Farmer R. D. The treatment of depression in UK general practice: selective serotonin reuptake inhibitors and tricyclic antidepressants compared. J Affect Disord. 2000 Aug;59(2):149–157. doi: 10.1016/s0165-0327(99)00147-0. [DOI] [PubMed] [Google Scholar]
- Middleton N., Gunnell D., Whitley E., Dorling D., Frankel S. Secular trends in antidepressant prescribing in the UK, 1975-1998. J Public Health Med. 2001 Dec;23(4):262–267. doi: 10.1093/pubmed/23.4.262. [DOI] [PubMed] [Google Scholar]
- Mintz J., Mintz L. I., Arruda M. J., Hwang S. S. Treatments of depression and the functional capacity to work. Arch Gen Psychiatry. 1992 Oct;49(10):761–768. doi: 10.1001/archpsyc.1992.01820100005001. [DOI] [PubMed] [Google Scholar]
- Potter W. Z. Psychotropic medications and work performance. J Occup Med. 1990 Apr;32(4):355–361. doi: 10.1097/00043764-199004000-00017. [DOI] [PubMed] [Google Scholar]
- Tilson H. H. Medication monitoring in the workplace: toward improving our system of epidemiologic intelligence. J Occup Med. 1990 Apr;32(4):313–319. doi: 10.1097/00043764-199004000-00011. [DOI] [PubMed] [Google Scholar]